Streptococcus Agalactiae Pathogenesis in Aquaculture Systems

Streptococcus agalactiae is a Gram-positive bacterium responsible for streptococcosis outbreaks that inflict severe economic losses in global aquaculture, particularly in tilapia and other freshwater species. Pathogenesis begins with colonisation of mucosal surfaces, followed by secretion of virulence factors such as capsular polysaccharide, haemolysin and hyaluronidase, which facilitate immune evasion, tissue invasion and systemic dissemination. Environmental stressors—especially elevated water temperature and crowding—enhance bacterial proliferation and compromise host defences. In infected fish, clinical signs range from erratic swimming and exophthalmos to meningitis and septicaemia, often leading to high mortality. Control measures encompass rigorous biosecurity, antimicrobial stewardship guided by serotype-specific susceptibility profiles and vaccination strategies designed to elicit both mucosal and systemic immunity. Advances in molecular typing and multiomics have deepened understanding of host–pathogen interactions, informing vaccine design and management practices that mitigate the global impact of S. agalactiae on aquaculture productivity.

Research from Nature Portfolio

Recent studies have demonstrated the potential of chimeric multiepitope vaccines engineered by immunoproteomic screening of antigenic proteins. Recombinant protein and DNA vaccine constructs have elicited significant protection in Nile tilapia, with relative percentage survival approaching 60–75% following experimental challenge. This approach offers a pathway towards multivalent formulations capable of controlling diverse streptococcal strains.

Investigations into inapparent adult infections have uncovered a predominant serotype Ia lineage in commercial tilapia farms, typified by a unique multilocus sequence type and a dominant pulsed-field gel electrophoresis profile. These findings highlight the role of asymptomatic carriers in pathogen persistence and underscore the need for active surveillance to prevent unnoticed spread within aquaculture facilities.

Streptococcus Agalactiae Pathogenesis in Aquaculture Systems publication trend

The graph below shows the total number of articles in streptococcus agalactiae pathogenesis in aquaculture systems across all publications each year (not limited to Nature Index journals).

Technical terms

Serotype: A classification of bacterial strains based on distinct surface antigens, often influencing virulence and antibiotic susceptibility.

Pulsed-field gel electrophoresis (PFGE): A method for separating large DNA fragments to generate bacterial strain-specific fingerprints.

Multilocus sequence typing (MLST): A genotyping technique analysing sequences of multiple housekeeping genes to define bacterial lineages.

Repetitive sequence-based PCR (REP-PCR): A DNA fingerprinting method using primers targeting repetitive genomic elements to distinguish bacterial strains.

Multiepitope vaccine: A vaccine construct combining epitopes from several antigenic proteins to induce broad and robust immune responses.

Capsular polysaccharide: A polysaccharide layer surrounding some bacteria that inhibits phagocytosis and contributes to virulence.

NOD-like receptor: A family of intracellular pattern-recognition receptors that detect bacterial components and activate innate immune signalling.

References

1. Research Advances on Tilapia Streptococcosis. Pathogens (2021).
2. Transcriptome and Proteome of Fish-Pathogenic Streptococcus agalactiae Are Modulated by Temperature. Frontiers in Microbiology (2018).
3. Susceptibility Profile and Epidemiological Cut-Off Values Are Influenced by Serotype in Fish Pathogenic Streptococcus agalactiae. Antibiotics (2023).
4. Streptococcus agalactiae Infection in Wild Trahira (Hoplias malabaricus) and Farmed Arapaima (Arapaima gigas) in Brazil: An Interspecies Transmission in Aquatic Environments Shared with Nile Tilapia (Oreochromis niloticus). Microorganisms (2024).
5. An Overview of Vaccination Strategies and Antigen Delivery Systems for Streptococcus agalactiae Vaccines in Nile Tilapia (Oreochromis niloticus). Vaccines (2016).
6. Novel Chimeric Multiepitope Vaccine for Streptococcosis Disease in Nile Tilapia (Oreochromis niloticus Linn.). Scientific Reports (2020).
7. Inapparent Streptococcus agalactiae infection in adult/commercial tilapia. Scientific Reports (2016).
8. Multiomics analyses reveal that NOD-like signaling pathway plays an important role against Streptococcus agalactiae in the spleen of tilapia. Fish & Shellfish Immunology (2019).